BM-MSCs in turn promoted the growth of T-ALL cells through FGF2 and FGFR2 interaction which activated PI3K/AKT/mTOR pathway of T-ALL cells. The gene discussed is FGFR2; the disease is acute lymphoblastic leukemia.